Literature DB >> 32468876

High Frequency of Asteroid Hyalosis Precludes Diabetic Retinopathy Screening With Smartphone-Based Retinal Camera in Brazilian Xavante Indians.

Fernando Korn Malerbi1, Amaury Lelis Dal Fabbro2, Regina Celia Santiago Moises3, João Paulo Botelho Vieira Filho3, Laercio Joel Franco2,3.   

Abstract

Entities:  

Keywords:  diabetic retinopathy; ethnicity; screening; telemedicine

Year:  2020        PMID： 32468876      PMCID： PMC7753867          DOI： 10.1177/1932296820929673

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  5 in total

1.  [Demographic profile of the Xavánte Indian population in Sangradouro-Volta Grande, Mato Grosso].

Authors:  L G Souza; R V Santos
Journal:  Cad Saude Publica       Date:  2001 Mar-Apr       Impact factor: 1.632

Review 2.  Asteroid hyalosis-a comprehensive review.

Authors:  Matin Khoshnevis; Sasha Rosen; J Sebag
Journal:  Surv Ophthalmol       Date:  2019-01-30       Impact factor: 6.048

3.  High prevalence of type 2 diabetes mellitus in Xavante Indians from Mato Grosso, Brazil.

Authors:  Amaury L Dal Fabbro; Laércio J Franco; Anderson S da Silva; Daniela S Sartorelli; Luana P Soares; Luciana F Franco; Patrícia C Kuhn; Regina S Moisés; João Paulo B Vieira-Filho
Journal:  Ethn Dis       Date:  2014       Impact factor: 1.847

4.  Diabetic retinopathy among Brazilian Xavante Indians.

Authors:  Carlos Gustavo M G Lima; Laercio Joel Franco; Amaury L Dal Fabbro; Edson Z Martinez; João Paulo Botelho Veira-Filho; Alexandre A C M Ventura; Leonardo Prevelato; Antonio Augusto V Cruz
Journal:  Diabetol Metab Syndr       Date:  2018-06-13       Impact factor: 3.320

5.  Genome-wide analysis in Brazilian Xavante Indians reveals low degree of admixture.

Authors:  Patricia C Kuhn; Andréa R V Russo Horimoto; José Maurício Sanches; João Paulo B Vieira Filho; Luciana Franco; Amaury Dal Fabbro; Laercio Joel Franco; Alexandre C Pereira; Regina S Moises
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.